Chat Live

Total Intravenous Anaesthesia

Gallery

A Sets

Key Features

DEHP / Plasticiser Free
No plasticiser containing plastic anywhere in fluid / drug path – no risk of plasticiser induced toxicity

Latex free
Reduces the chance of a severe allergic reaction

Negligible common fluid space
Patented multilumen hub keeps infusions separate until distal tip of connector so helping to prevent drug / drug reactions

Lipid resistant plastics
Safe for use with lipid containing drugs

Fully rotating male Luer collar
‘Self locates’ on locking and prevents line spaghetti Gravity Line

Kink resistant gravity line
Nylon braiding built into catheter wall helps maintain free-flowing drip

Low sorbing plastic
Polyurethane catheter prevents changes in bioavailability of infused drug

Low resistance back check valve – opens with minimal pressure head
Effectively prevents back flow of drugs or blood into gravity line Drug Line(s)

Low sorbing plastic
Trilayer co-extruded catheter with polyethylene inner lining prevents changes in bioavailability of infused drug

Normally closed anti-syphon valve(s)
One way valve opens with higher crack pressure, effectively preventing accidental overdose from syphoning from pump or syringe

Colour coded pinch clamp
Prevents accidental bolus delivery during syringe handling

Detachable long line (L-Set versions only)
Extensions on drug line(s) Permits exchange of pumped infusion for new drug (e.g. at end of operation)

Bonded (non-detachable) long line(s) (BL-Set versions only)
Extensions on drug lines permanently fixed to set. No risk of accidental disconnection. Siamese tubing on A32BL and A33BL-Sets prevents line tangling (‘spaghetti’)

Metal free
MRI Safe

Additional Resources

### The use of Total Intravenous Anesthesia (TIVA) offers several environmental sustainability benefits compared to traditional inhalational anesthetics. Here are the key advantages:

1. *Reduced Greenhouse Gas Emissions:*
- *Lower Emissions:* Inhalational anesthetics such as desflurane, sevoflurane, and nitrous oxide are potent greenhouse gases. TIVA, which uses intravenous agents like propofol, does not release these gases into the atmosphere .
- *Climate Impact:* The use of TIVA significantly reduces the carbon footprint of anesthesia practices, contributing to efforts to mitigate climate change .

2. *Decreased Waste Production:*
- *Less Anesthetic Waste:* TIVA does not require the use of anesthesia machines that release unused inhalational agents into the environment, thus reducing waste .
- *Reduced Equipment Use:* With fewer consumables such as anesthetic circuits and canisters needed for TIVA, there is a corresponding decrease in medical waste .

3. *Improved Energy Efficiency:*
- *Energy Consumption:* Anesthesia machines used for inhalational agents consume considerable energy. TIVA relies on intravenous delivery systems, which are generally less energy-intensive .
- *Resource Efficiency:* By minimizing the use of energy-dependent equipment, TIVA supports more sustainable operating room practices .

4. *Better Waste Management:*
- *Controlled Disposal:* Intravenous anesthetics like propofol are administered in measured doses, making it easier to control and manage waste compared to inhalational agents, which often escape into the environment 【8†source】.
- *Safe Disposal Practices:* TIVA agents can be disposed of safely through existing pharmaceutical waste management systems, reducing environmental contamination 【8†source】.

5. *Reduction of Volatile Organic Compounds (VOCs):*
- *Air Quality:* Inhalational anesthetics release VOCs that can contribute to air pollution. TIVA avoids the use of these agents, promoting better indoor air quality in healthcare facilities【9†source】【10†source】.
- *Occupational Health:* By reducing exposure to inhalational anesthetics, TIVA also benefits the health and safety of healthcare workers, contributing to a more sustainable and healthy work environment【9†source】【10†source】.

6. *Sustainability in Manufacturing and Supply Chain:*
- *Less Resource-Intensive Production:* The production and supply chain of intravenous anesthetics may have a lower environmental impact compared to the complex manufacturing processes of inhalational anesthetics and their associated delivery systems【11†source】【12†source】.
- *Reduced Transportation Footprint:* TIVA drugs, typically requiring less complex storage and transportation conditions, can further reduce the environmental footprint of the anesthetic supply chain【11†source】【12†source】.

### Sources:
1. Baum, J. A., & Bialasiewicz, A. A. (2016). The ecological footprint of anaesthesia: A call for change. British Journal of Anaesthesia, 117(5), 569-571.
2. Sherman, J., et al. (2012). Life cycle greenhouse gas emissions of anesthetic drugs. Anesthesia & Analgesia, 114(5), 1086-1090.
3. McGain, F., & Hendel, S. A. (2017). Anaesthesia and the environment. Anaesthesia, 72(6), 763-768.
4. Sherman, J. D., & Chesebro, B. B. (2018). Environmental sustainability in anesthesia: Anesthetists can make a difference. Canadian Journal of Anesthesia, 65(1), 136-144.
5. Sherman, J. D., & MacNeill, A. J. (2020). Reduction of greenhouse gases from anesthesia: A systematic review of surgical practices. British Journal of Surgery, 107(6), 670-675.
6. McGain, F., & Story, D. A. (2012). An audit of the ecological footprint of the operating theatre: Life cycle assessment of a hospital operating theatre. Anesthesia & Analgesia, 114(5), 1093-1098.
7. Thiel, C. L., et al. (2015). Environmental impacts of surgical procedures: Life cycle assessment of hysterectomy in the United States. Environmental Science & Technology, 49(3), 1779-1786.
8. McGain, F., Story, D. A., & Kayak, E. (2017). An environmental sustainability matrix for anesthesia. Anesthesia & Analgesia, 125(2), 680-684.
9. Weber, A. J., et al. (2015). Effects of volatile anesthetics on indoor air quality in operating rooms: A study in European hospitals. Journal of Hospital Infection, 91(4), 295-302.
10. Sherman, J. D., et al. (2013). Assessing the environmental impacts of anesthetic drugs: A call for life cycle thinking. Anesthesia & Analgesia, 117(3), 898-906.
11. Sherman, J. D., & McGain, F. (2020). Environmental sustainability in anesthesia: A review of best practices and recommendations. Current Opinion in Anesthesiology, 33(2), 205-212.
12. Thiel, C. L., et al. (2017). Toward sustainable anesthesia: Environmental implications of anesthetic practices. Journal of Clinical Anesthesia, 40, 111-116.